AnGes’ HGF Therapy Could Debut Before Year-End to Become 1st Gene Therapy in Japan; 2 More Products Anticipated in 2019

The first gene therapy in Japan is about to debut. Osaka-based biotech AnGes’ hepatocyte growth factor (HGF) gene therapy beperminogene perplasmid could receive approval by the end of the year for the treatment of critical limb ischemia (CLI; arteriosclerosis obliterans...read more